Αποτελέσματα Αναζήτησης
2 Νοε 2020 · A pre-IND meeting is a Type B meeting held between a sponsor and the FDA. The primary purpose of a pre-IND meeting is to discuss safety issues related to the investigational drug; issues related to pre-clinical studies, clinical trial design, and manufacturing; and to identify potential clinical hold issues.
This good review practice (GRP) document was prepared to assist FDA clinical review staff in reviewing clinical submissions to an investigational new drug application (IND)
The ISPE GMP Audit Checklist is designed to aid in the systematic audit of a facility that manufacturers drug components or finished products.
The purpose of this guidance is to provide sponsors and the review staff in the Center for Drug Evaluation and Research (CDER) at the Food and Drug Administration (FDA) with information regarding target product profiles (TPPs). A TPP is a format for a summary of a drug development program2 described in terms of labeling concepts. A TPP can be ...
A Good Review Practice, or GRP, is a “documented best practice” within CDER that discusses any aspect related to the process, format, content and/or management of a product review.
16 Αυγ 2024 · NIH applicants can use a template with instructional and sample text to help write clinical protocols for the following types of research: Phase 2 or 3 clinical trials that require Investigational New Drug applications (IND) or Investigational Device Exemption (IDE) applications; Behavioral and social sciences research involving humans
The FDA uses postmarket requirement and commitment studies to gather additional information about a product's safety, efficacy, or optimal use. New Drug Application (NDA)--This is the...